Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy

Back

ESC Premium Access

Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy

Session: New insights for acute coronary syndrome pharmacotherapy

Topic: Thrombosis, Platelets, and Coagulation

Speaker: Doctor L. Lugo Gavidia (Santiago de Queretaro, MX)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Leslie Marisol Lugo Gavidia

CONSAM, Santiago de Queretaro (Mexico)

0 follower

8 more presentations in this session

Revacept, an inhibitor of platelet adhesion in symptomatic carotid stenosis: Results from a phase II study

Speaker: Assistant Professor K. Groschel (Mainz, DE)

Access

Abstract

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome and multivessel coronary artery disease: a post-hoc analysis of the TROPICAL-ACS trial

Speaker: Assistant Professor K. Rizas (Munich, DE)

Effects of Interleukin-1 blockade with Anakinra on cardiac function in ST-segment elevation acute myocardial infarction: results from the VCUART3 echocardiography study

Speaker: Doctor A. Abbate (Charlottesville, US)

New possibilities of thrombolytic therapy in patients with STEMI according to a multicenter clinical study FRIDOM1.

Speaker: Doctor E. Gerasimets (Moscow, RU)

Heart transplant recipients with cardiac allograft vasculopathy have increased platelet aggregation before and after low-dose aspirin therapy

Speaker: Doctor K. Bjerre (Aarhus, DK)

Access the full session

New insights for acute coronary syndrome pharmacotherapy

Speakers: Doctor L. Lugo Gavidia, Assistant Professor K. Groschel, Assistant Professor K. Rizas, Doctor A. Abbate, Doctor E. Gerasimets...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy

About the speaker

Doctor Leslie Marisol Lugo Gavidia

8 more presentations in this session

Revacept, an inhibitor of platelet adhesion in symptomatic carotid stenosis: Results from a phase II study

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome and multivessel coronary artery disease: a post-hoc analysis of the TROPICAL-ACS trial

Effects of Interleukin-1 blockade with Anakinra on cardiac function in ST-segment elevation acute myocardial infarction: results from the VCUART3 echocardiography study

New possibilities of thrombolytic therapy in patients with STEMI according to a multicenter clinical study FRIDOM1.

Heart transplant recipients with cardiac allograft vasculopathy have increased platelet aggregation before and after low-dose aspirin therapy

Access the full session

New insights for acute coronary syndrome pharmacotherapy

About the event

ESC Congress 2019

ESC 365 is supported by